Wash U Team Aims to Develop Sequencing-Based Individualized Vaccines for Breast Cancers
April 26, 2011
Wash U Team Aims to Develop Sequencing-Based Individualized Vaccines for Breast Cancers
The team plans to use sequencing to create a polyepitope DNA vaccine that will contain "fragments from each individual mutated protein" for individual patients. They hope to begin human trials for the vaccine within the next two years.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Wash U Awarded $6.5M Grant to Develop Sequencing-Based Breast Cancer Vaccine
April 19, 2011 / Clinical Sequencing News - Sequencing Guides Cancer Treatment, but Illustrates Need for Regulatory and Ethical Framework
April 26, 2011 / Clinical Sequencing News - Wash U Team Looks to Expand on Initial Success of Sequencing in Breast Cancer Clinical Trial
April 5, 2011 / Clinical Sequencing News - Sequencing Studies Lead to New Clinical Trial for Overlooked HER2 Mutations in Breast Cancer
December 12, 2012 / Clinical Sequencing News - Swedish Project Will Sequence Tumor Exomes to Study Drug Resistance, Develop Companion Tests
August 31, 2011 / Clinical Sequencing News